EverSource Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Buy
6,325
+2,932
+86% +$7.45K ﹤0.01% 2503
2026
Q1
$6.65K Buy
3,393
+2,393
+239% +$5.61K ﹤0.01% 3124
2025
Q4
$2.71K Buy
1,000
+947
+1,787% +$3.11K ﹤0.01% 3387
2025
Q3
$224 Sell
53
-6
-10% -$26 ﹤0.01% 4087
2025
Q2
$294 Sell
59
-51
-46% -$222 ﹤0.01% 4004
2025
Q1
$485 Buy
110
+68
+162% +$319 ﹤0.01% 3469
2024
Q4
$195 Buy
+42
New +$231 ﹤0.01% 3436
2023
Q4
Sell
-600
Closed -$3.38K 2680
2023
Q3
$3.38K Hold
600
﹤0.01% 1848
2023
Q2
$3.31K Hold
600
﹤0.01% 1889
2023
Q1
$3.75K Sell
600
-400
-40% -$2.23K ﹤0.01% 1739
2022
Q4
$4.66K Buy
+1,000
New +$4.93K ﹤0.01% 1635

Other funds holding GDRX

EverSource Wealth Advisors's GDRX Position: Q2 2026 in Review

EverSource Wealth Advisors increased its GoodRx Holdings (GDRX) stake by 86% in Q2 2026, buying an estimated $7.45K and bringing the position to 6,325 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2503.

EverSource Wealth Advisors first reported a position in GDRX in Q4 2022 and has held it in 11 quarters since. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • EverSource Wealth Advisors held 6,325 shares of GoodRx Holdings worth $18.2K as of Q2 2026.
  • EverSource Wealth Advisors bought 2,932 GoodRx Holdings shares in Q2 2026, an estimated $7.45K.
  • GoodRx Holdings made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2503 holding.
  • EverSource Wealth Advisors first reported a position in GoodRx Holdings in Q4 2022 and has held it in 11 quarters since.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.